<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>2076309</identifier>
<setSpec>0001-6519</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Garrido, F</dc:author>
<dc:author>Ruiz-Cabello, F</dc:author>
<dc:author>Esteban, F</dc:author>
<dc:author>Concha, A</dc:author>
<dc:description xml:lang="en">A series of 60 primary laryngeal and hypopharyngeal tumours, 24 lymph node metastasis and normal tissue were evaluated in frozen sections for the expression of MHC class I antigens, using monoclonal antibodies. Normal distant mucosa of the larynx reacted to anti class I antibodies. In 13 primary tumours HLA class I antigens were not found. The remaining 47 showed a strong reaction to anti HLA-ABC (heavy chain) and anti beta 2-microglobulin, although in 5 cases staining was not observed with anti HLA-A locus specific monoclonal antibodies. Other tumour showed a selective loss of HLA-B antigens. These selective losses were confirmed using the correspondent anti-HLA polymorphic monoclonal antibodies. We have found differences in HLA class I expression when comparing primary tumours and autologous metastasis (3/15 cases). Finally, to further analyse the mechanism responsible for the HLA phenotypic changes observed, immunoprecipitation and SDS-PAGE of class I antigens, Northern and Southern blot analysis of MHC class I genes were performed. We have not detected class I gene rearrangement using HLA coding and locus specific non coding probes. However we have found a class I transcription defect in a class I negative tumour.</dc:description>
<dc:type>English Abstract</dc:type>
<dc:language>es</dc:language>
<dc:date>1990 Sep-Oct </dc:date>
<dc:title xml:lang="es">Modulación inmunológica de la agresividad tumoral en el cáncer de laringe. I. Estudios genético y molecular de los antígenos HLA de clase I.</dc:title>
<dc:title xml:lang="en">[Immunologic modulation of tumor aggressiveness in cancer of the larynx. I. Genetic and molecular studies of HLA class I antigens].</dc:title>
<dc:publisher>Acta otorrinolaringologica espanola</dc:publisher>
</metadata>
</record>
</pubmed-document>
